These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12221014)
1. The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Fujimura K; Bessho K; Okubo Y; Kusumoto K; Segami N; Iizuka T Arch Oral Biol; 2002 Aug; 47(8):577-84. PubMed ID: 12221014 [TBL] [Abstract][Full Text] [Related]
2. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Nakamura Y; Tensho K; Nakaya H; Nawata M; Okabe T; Wakitani S Bone; 2005 Mar; 36(3):399-407. PubMed ID: 15777655 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity. Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346 [TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats. Kakudo N; Kusumoto K; Kuro A; Ogawa Y Wound Repair Regen; 2006; 14(3):336-42. PubMed ID: 16808813 [TBL] [Abstract][Full Text] [Related]
5. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ectopic osteoinduction in vivo by recombinant human BMP-2 and recombinant Xenopus BMP-4/7 heterodimer. Kusumoto K; Bessho K; Fujimura K; Akioka J; Ogawa Y; Iizuka T Biochem Biophys Res Commun; 1997 Oct; 239(2):575-9. PubMed ID: 9344873 [TBL] [Abstract][Full Text] [Related]
7. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Okubo Y; Bessho K; Fujimura K; Konishi Y; Kusumoto K; Ogawa Y; Iizuka T Int J Oral Maxillofac Surg; 2000 Feb; 29(1):62-6. PubMed ID: 10691147 [TBL] [Abstract][Full Text] [Related]
8. Comparison of recombinant and purified human bone morphogenetic protein. Bessho K; Kusumoto K; Fujimura K; Konishi Y; Ogawa Y; Tani Y; Iizuka T Br J Oral Maxillofac Surg; 1999 Feb; 37(1):2-5. PubMed ID: 10203213 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2. Okubo Y; Bessho K; Fujimura K; Kusumoto K; Ogawa Y; Tani Y; Iizuka T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Jan; 87(1):34-8. PubMed ID: 9927077 [TBL] [Abstract][Full Text] [Related]
10. Intramuscular osteoinduction and bone marrow formation by the implantation of rhBMP-2 with atelopeptide type I collagen. Kusumoto K; Bessho K; Fujimura K; Ogawa Y; Iizuka T Br J Oral Maxillofac Surg; 1997 Dec; 35(6):433-7. PubMed ID: 9486451 [TBL] [Abstract][Full Text] [Related]
11. Differential growth factor control of bone formation through osteoprogenitor differentiation. Chaudhary LR; Hofmeister AM; Hruska KA Bone; 2004 Mar; 34(3):402-11. PubMed ID: 15003788 [TBL] [Abstract][Full Text] [Related]
13. [The impact of bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) on osseointegration, degradation and biomechanical properties of a synthetic bone substitute]. Kessler S; Mayr-Wohlfart U; Ignatius A; Puhl W; Claes L; Günther KP Z Orthop Ihre Grenzgeb; 2003; 141(4):472-80. PubMed ID: 12929007 [TBL] [Abstract][Full Text] [Related]
14. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Cole BJ; Bostrom MP; Pritchard TL; Sumner DR; Tomin E; Lane JM; Weiland AJ Clin Orthop Relat Res; 1997 Dec; (345):219-28. PubMed ID: 9418644 [TBL] [Abstract][Full Text] [Related]
15. Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2. Okubo Y; Bessho K; Fujimura K; Kusumoto K; Ogawa Y; Iizuka T Clin Oral Implants Res; 2002 Feb; 13(1):80-5. PubMed ID: 12005149 [TBL] [Abstract][Full Text] [Related]
16. Preclinical study of recombinant human bone morphogenetic protein-2: application of hyperbaric oxygenation during bone formation under unfavourable condition. Okubo Y; Bessho K; Fujimura K; Kusumoto K; Suzuki T; Segami N; Ogawa Y; Iizuka T Int J Oral Maxillofac Surg; 2003 Jun; 32(3):313-7. PubMed ID: 12767880 [TBL] [Abstract][Full Text] [Related]
17. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Hanada K; Dennis JE; Caplan AI J Bone Miner Res; 1997 Oct; 12(10):1606-14. PubMed ID: 9333121 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous administration of lactone form of simvastatin stimulates ectopic osteoinduction by rhBMP-2. Sugiyama T; Nakagawa T; Sato C; Fujii T; Mine K; Shimizu K; Murata T; Tagawa T Oral Dis; 2007 Mar; 13(2):228-33. PubMed ID: 17305627 [TBL] [Abstract][Full Text] [Related]
19. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Barron M; Gao M; Lough J Dev Dyn; 2000 Jun; 218(2):383-93. PubMed ID: 10842364 [TBL] [Abstract][Full Text] [Related]
20. Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2. Gruber R; Weich HA; Dullin C; Schliephake H Clin Oral Implants Res; 2009 Jan; 20(1):24-30. PubMed ID: 19126104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]